ArticleJournal of virology2025

Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivity.

Parker J Jamieson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.